Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Metal embedded in a tablet.
| Brand name | METHYLPHENIDATE HYDROCHLORIDE |
| Generic name | METHYLPHENIDATE HYDROCHLORIDE |
| Active ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
| Distributed by / for | Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512 |
| NDC | 57664-230-88 |
| Full product label | Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide |
| Quantity | 7313 bottles |
| Recall initiated | 2023-07-13 |
| Report date | 2023-08-02 |
| Recall completed | 2024-02-12 |
| Recall number | D-0940-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗